Editorially Independent Content, Supported With Advertising From Genentech

Retained PFO After Autologous Retinal Transplant: A Cause for Concern?

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Show Description +

Prof. David Keegan and Tamer Mahmoud, MD, PhD, discuss the potential for retained PFO after ART. According to Dr. Mahmoud, retained PFO may occur, but is rarely, if ever, problematic--and there may be cases where PFO is preferable to using silicone oil.

Posted: 11/16/2021

Keywords:

Autologous Retina Transplant

•

PFO

•

perfluorooctane

Up Next

Name: Retained PFO After Autologous Retinal Transplant: A Cause for Concern?
Uploaded: 2021-11-16T21:18:00+00:00
Description: Prof. David Keegan and Tamer Mahmoud, MD, PhD, discuss the potential for retained PFO after ART. According to Dr. Mahmoud, retained PFO may occur, but is rarely, if ever, problematic--and there may be cases where PFO is preferable to using silicone oil.

Is it Time to Reconsider Vitrectomy for Symptomatic Vitreous Opacities?

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Second-Generation IMT: Same Results, Improved Delivery

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Autologous Retinal Transplant for Complex Macular Holes

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Extending the Interval: Surgical Options for AMD Maintenance Therapy

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Improving Visual Function in a Patient With Symptomatic Vitreous Opacities

Maria Berrocal, MD

Symptomatic Vitreous Opacities: When to Induce a PVD

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Patient Management After Autologous Retinal Transplant

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Back to All Videos

Retained PFO After Autologous Retinal Transplant: A Cause for Concern?

Carl Regillo, MD; Maria Berrocal, MD; Prof. David Keegan; and Tamer Mahmoud, MD, PhD

Posted: 11/16/2021

Keywords:

Autologous Retina Transplant

•

PFO

•

perfluorooctane

Please log in to leave a comment.

Editorial Feature:

Innovations in Surgical Retina

Retained PFO After Autologous Retinal Transplant: A Cause for Concern?

Up Next

Retained PFO After Autologous Retinal Transplant: A Cause for Concern?